# HFNO Reducing the Incidence of Hypoxia for Hysteroscopy Sedated With Propofol

> **NCT05049395** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 960 (estimated)

## Conditions studied

- Endometritis
- Tuberculous Endometritis
- Subseptate Uterus
- Endometrial Polyps

## Interventions

- **DEVICE:** High Flow Nasal Cannula oxygen (HFNO)
- **DEVICE:** Regular oxygen

## Key facts

- **NCT ID:** NCT05049395
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-30
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 960 (ESTIMATED)
- **Last updated:** 2021-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05049395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05049395, "HFNO Reducing the Incidence of Hypoxia for Hysteroscopy Sedated With Propofol". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05049395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*